CLINICAL_TRIALS
trial_result
· 2012-11-06
Clinical Trial Update: Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma [Phase 2]
Summary
Phase 2 clinical trial update evaluating protracted etoposide during induction therapy for high-risk neuroblastoma has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2012-11-06